SEVERANCE AGREEMENTSeverance Agreement • March 30th, 2020 • Aileron Therapeutics Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 30th, 2020 Company Industry JurisdictionThis SEVERANCE AGREEMENT (this “Agreement”) is made and entered into as of December 12, 2019 by and between Rick Wanstall (“Executive”) and Aileron Therapeutics, Inc. (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • March 29th, 2019 • Aileron Therapeutics Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionThis SEVERANCE AGREEMENT (this “Agreement”) is made and entered into as of October 1, 2018 by and between Donald Dougherty (“Executive”) and Aileron Therapeutics, Inc. (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • March 29th, 2019 • Aileron Therapeutics Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 29th, 2019 Company Industry JurisdictionThis SEVERANCE AGREEMENT (this “Agreement”) is made and entered into as of November 5, 2018 by and between Allen Annis (“Executive”) and Aileron Therapeutics, Inc. (the “Company”).
SEVERANCE AGREEMENTSeverance Agreement • November 7th, 2018 • Aileron Therapeutics Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 7th, 2018 Company Industry JurisdictionThis SEVERANCE AGREEMENT (this “Agreement”) is made and entered into as of September 6, 2018 by and between Manuel C. Alves Aivado, M.D., Ph.D. (“Executive”) and Aileron Therapeutics, Inc. (the “Company”).